Company intelligence / Profile preview

Emosoxe Biotech International

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Emosoxe Biotech is a life sciences company dedicated to the advancement of exosome-based research and clinical applications. Based in Suzhou, China, the company offers a comprehensive suite of products and services for the isolation, purification, and analysis of extracellular vesicles. Their proprietary technology platform enables high-yield and high-purity extraction of exosomes from various biofluids, supporting research in oncology, immunology, and regenerative medicine. Emosoxe also provides specialized services such as Nanoparticle Tracking Analysis (NTA) and exosome proteomics to facilitate biomarker discovery and drug delivery development.

Therapeutic areas: OncologyOther
Modalities: Exosome-based therapyExosome-based diagnostics
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Emosoxe Biotech International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emosoxe Biotech International.

Explore the full profile